Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Active Pharmaceutical Ingredient (API) Market Report 2021-2025: Opportunities in Advancements in API Manufacturing, Growth in the CMOs, & Emergence of Biosimilars Market

      Research and Markets Logo

      News provided by

      Research and Markets

      May 10, 2021, 08:00 ET

      Share this article

      Share this article


      DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

      The Global Active Pharmaceutical Ingredient Market is estimated to be USD 187.23 Bn in 2020 and is expected to reach USD 255.56 Bn by 2025, growing at a CAGR of 6.42%.

      Market Dynamics

      Key factors such as the increasing incidence of chronic diseases with a rising geriatric population have significantly led to the market growth for Active Pharmaceutical Ingredient (API) market. Similarly, the increasing dependence on API formulation in developing nations with lower costs and the rising investments of the pharmaceutical companies in API drugs is additionally benefitting the market growth.

      Moreover, the advancements in API manufacturing with advancements in the API synthesis process and the evolving biosimilars market are creating opportunities in the Global Active Pharmaceutical Ingredient Market.

      However, the price control policies and high costs of manufacturing API drugs are restraining the growth of the market.

      Recent Developments

      • Pfizer US has signed an agreement with Gilead Sciences to manufacture and supply Gilead's antiviral drug (Remdesivir) for the treatment of COVID-19. - 7th August 2020
      • Novartis Switzerland has acquired Aspen's Japanese operations to strengthen its position in the global generics and off-patent medicines market. - 8th August 2020

      Market Segmentation

      • By Type, the market is classified as innovative active pharmaceutical ingredients, generic active pharmaceutical ingredients. Amongst the two, the innovative active pharmaceutical ingredients segment is estimated to hold the highest market share.
      • By Molecule, the market is classified as small molecule and large molecule. Amongst the two, the small molecule is estimated to hold the highest market share.
      • By Product Type, the market is classified as High Potent API and Low Potent API. Amongst the two, the High Potent API segment is estimated to hold the highest market share.
      • By Formulation Type, the market is classified as oral, topical, injectable, and drops. Amongst all, the oral segment is estimated to hold the highest market share.
      • By Manufacturing Type, the market is classified as Captive API, Merchant API. Amongst the two, the Captive API segment is estimated to hold the highest market share.
      • By Synthesis Type, the market is classified as Biotech API, Monoclonal Antibodies, Recombinant Proteins, Vaccines, and Synthetic API. Amongst the two, the Synthetic API segment is estimated to hold the highest market share during the forecast period.
      • By Drug Type, the market is classified as prescription drugs and OTC drugs. Amongst the two, the prescription drugs segment is estimated to hold the highest market share.
      • By Application, the market is classified as communicable diseases, oncology, diabetes, cardiovascular disease, pain management, respiratory diseases, and other therapeutic applications. Amongst all, the cardiology segment is estimated to hold the highest market share.
      • By Geography, North America is projected to lead the market.

      Company Profiles

      Some of the companies covered in this report are Cipla, Inc., Merck & Co., Inc., Albemarle Corporation, Pfizer Inc, Novartis, Sanofi, Abbvie, Aurobindo Pharma, Viatris Inc. (formerly Mylan N.V.).

      Key Topics Covered:

      1 Report Description
      1.1 Study Objectives
      1.2 Market Definition
      1.3 Currency
      1.4 Years Considered
      1.5 Language
      1.6 Key Stakeholders

      2 Research Methodology
      2.1 Research Process
      2.2 Data Collection and Validation
      2.3 Market Size Estimation
      2.4 Assumptions of the Study
      2.5 Limitations of the Study

      3 Executive Summary

      4 Market Overview
      4.1 Introduction
      4.2 Market Dynamics
      4.2.1 Drivers
      4.2.1.1 Increasing incidence of chronic diseases
      4.2.1.2 Technological Advancements in active pharmaceutical ingredients
      4.2.1.3 Growing demand of API formulation in developing countries
      4.2.1.4 Adoption of AI based tools and organ-on-chip models in drugs discovery and development
      4.2.2 Restraints
      4.2.2.1 Regulatory policies and unfavourable drug price control policies
      4.2.2.2 High manufacturing cost
      4.2.3 Opportunities
      4.2.3.1 Advancements in API manufacturing
      4.2.3.2 Growth in the contract manufacturing organizations (CMOs)
      4.2.3.3 Emergence of biosimilars market
      4.2.4 Challenges
      4.2.4.1 Increasing penetration of counterfeit drugs
      4.3 Trends

      5 Market Analysis
      5.1 Porter's Five Forces Analysis
      5.2 Impact of COVID-19
      5.3 Ansoff Matrix Analysis

      6 Global Active Pharmaceutical Ingredient Market, By Type
      6.1 Introduction
      6.2 Innovative Active Pharmaceutical Ingredients
      6.3 Generic Active Pharmaceutical Ingredients

      7 Global Active Pharmaceutical Ingredient Market, By Molecule Type
      7.1 Introduction
      7.2 Small Molecule
      7.3 Large Molecule

      8 Global Active Pharmaceutical Ingredient Market, By Product Type
      8.1 Introduction
      8.2 High Potent APIs
      8.3 Low Potent APIs

      9 Global Active Pharmaceutical Ingredient Market, By
      9.1 Introduction
      9.2 Oral
      9.3 Topical
      9.4 Injectables
      9.5 Drops

      10 Global Active Pharmaceutical Ingredient Market, By Manufacturer type
      10.1 Introduction
      10.2 Captive API
      10.3 Merchant API
      10.3.1 By Type
      10.3.1.1 Merchant Innovative API Manufacturers
      10.3.1.2 Merchant Generic API Manufacturers
      10.3.2 By Type of Synthesis
      10.3.2.1 Merchant Synthetic API Manufacturers
      10.3.2.2 Merchant Biotech API Manufacturers

      11 Global Active Pharmaceutical Ingredient Market, By Synthesis Type
      11.1 Introduction
      11.2 Biotech API
      11.2.1 By Type
      11.2.1.1 Innovative Biotech APIS
      11.2.1.2 Generic Biotech APIS
      11.2.2 By Product
      11.2.2.1 Monoclonal Antibodies
      11.2.2.2 Hormones & Growth Factors
      11.2.2.3 Cytokines
      11.2.2.4 Fusion Proteins
      11.2.2.5 Recombinant Vaccines
      11.2.2.6 Therapeutic Enzymes
      11.2.2.7 Blood Factors
      11.2.3 By Expression System
      11.2.3.1 Mammalian Expression Systems
      11.2.3.2 Microbial Expression Systems
      11.2.3.3 Yeast Expression Systems
      11.2.3.4 Insect Expression Systems
      11.2.3.5 Other Expression Systems
      11.3 Synthetic API
      11.3.1 Innovative Synthetic APIs
      11.3.2 Generic Synthetic APIs

      12 Global Active Pharmaceutical Ingredient Market, By Drug Type
      12.1 Introduction
      12.2 Prescription Drugs
      12.3 Over-the-counter Drugs

      13 Global Active Pharmaceutical Ingredient Market, By Application
      13.1 Introduction
      13.2 Communicable Diseases
      13.3 Oncology
      13.4 Diabetes
      13.5 Cardiovascular Disease
      13.6 Pain management
      13.7 Respiratory Diseases
      13.8 Other Therapeutic Applications

      14 Global Active Pharmaceutical Ingredient Market, By Geography

      15 Competitive Landscape
      15.1 Competitive Quadrant
      15.2 Market Share Analysis
      15.3 Competitive Scenario
      15.3.1 Mergers & Acquisitions
      15.3.2 Agreement, Collaborations, & Partnerships
      15.3.3 New Product Launches & Enhancements
      15.3.4 Investments & Funding

      16 Company Profiles

      • AbbVie, Inc.
      • Boehringer Ingelheim International GmbH
      • Bristol-Myers Squibb Company
      • Cipla, Inc.
      • Merck & Co., Inc.
      • Albemarle Corporation
      • Aurobindo Pharma
      • Teva Pharmaceutical Industries Ltd.
      • Sun Pharmaceutical Industries Ltd.
      • Dr. Reddy's Laboratories Ltd.
      • Pfizer, Inc.
      • Novartis Ag
      • Sanofi
      • Eli Lilly and Company
      • GlaxoSmithKline Plc
      • Viatris Inc (Formerly Mylan N.V.)
      • Hoffmann-La Roche Ltd.
      • Astrazeneca
      • Dr. Reddy's Laboratories Ltd
      • Roche Holding AG

      For more information about this report visit https://www.researchandmarkets.com/r/vbzwt

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]   

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1904
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.